Advanced search
Publication Cover
Aging Health Volume 7, 2011 - Issue 5
Journal homepage
49
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Promoting the Sexual Health of the Older Couple

Johannes Bitzer† Department of Obstetrics & Gynecology, University Hospital Basel, Basel, Switzerland. [email protected]View further author information
Pages 681-693 | Published online: 12 Oct 2011

Bibliography

  • Cort E , MonroeB, OliviereD. Couples in palliative care. Sex. Marital Ther.19, 337 (2004).
  • Montague DK , JarowJP, BroderickGAet al. Chapter 1: The management of erectile dysfunction: an AUA update. J. Urol. 174, 230 (2005).
  • Bitzer J , PlatanoG, TschudinS, AlderJ. Sexual counseling in elderly couples. J. Sex Med.5(9), 2027–2043(2008).
  • Tressel Lindau S , SchummLP, LaumannEO, LewinsonW, MuircheartaighCA, WaiteLJ. A study of sexuality and health among older adults in the United States. N. Engl. J. Med.357, 762–774(2007).
  • Hayes RD , DennersteinL. Aging issues. In: Women‘s Sexual Function and Dysfunction. Goldstein I, Meston CM, Davis SR, Traish AM (Eds). Taylor & Francis, Abingdon, UK (2006).
  • Shifren JL , MonzBU, RussoPA, SegretiA, JohannesCB. Sexual problems and distress in United States women. Prevalence and correlates. Obstet. Gynecol.112(5), 970–978(2008).
  • Laumann EO , PaikA, RosenRC. Sexual dysfunction in the United States, prevalence and predictors. JAMA281, 537 (1999).
  • Araujo AB , MohrBA, McKinlayJB. Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J. Am. Geriatr. Soc.52, 1502 (2004).
  • Bacon CG , MittlemanMA, KawachiI, GiovannucciE. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann. Intern. Med.139, 161 (2003).
  • Smith LJ , MulhallJP, DeveciS, MonaghanN, ReidMC. Sex after seventy: a pilot study of sexual function in older persons. J. Sex. Med.4(5), 1247–1253(2007).
  • Blumel JE , Castel-BrancoC, CancelloMJet al. Impairment of sexual activity in middle-aged women in Chile. Menopause 11, 78–81(2004).
  • Nappi R , SaloniaA, TraishAM, van Lunsen RH, Vardi Y, Kodiglu A. Goldstein clinical biologic pathophysiologies of women‘s sexual dysfunction. J. Sex Med.2(1), 4–25(2005).
  • Bitzer J , PlatanoG, TschudinS, AlderJ. Sexual counseling for women in the context of physical diseases – a teaching model for physicians. J. Sex Med.4, 29–37(2007).
  • Salonia A . Medical conditions associated with female sexual dysfunction. In: Women‘s Sexual Function and Dysfunction: Study, Diagnosis and Treatment. Goldstein I, Meston CM, Davis SR, Traish AM (Eds). Taylor & Francis, Abingdon, UK (2006).
  • Bitzer J , AlderJ. Diabetes and female sexual health. Womens Health (Lond. Engl.)5(6), 629–636(2009).
  • Bachmann GA , LeiblumSR. The impact of hormones on menopausal sexuality: a literature review. Menopause11, 120–130(2004).
  • Dennerstein L . Sexuality, midlife, and menopause. Menopause15(2), 221–222(2008).
  • Fobair P , SpiegelD. Concerns about sexuality after breast cancer. Cancer J.15(1), 19–26(2009).
  • Chiurlia E , D‘AmicoR, RattiCet al. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 46, 1503 (2005).
  • Esposito K , GiuglianoF, Di Palo C et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA291, 2978 (2004).
  • Ko DT , HebertPR, CoffeyCSet al. β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288, 351 (2002).
  • Briganti A , GallinaA, SuardiNet al. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. J. Sex Med. 7(7), 2521–2531(2010).
  • Pinkawa M , FischedickK, GagelBet al. Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. BMC Cancer 24(9), 296 (2009).
  • Dalkin BL , ChristopherBA. Potent men undergoing radical prostatectomy: a prospective study measuring sexual health outcomes and the impact of erectile dysfunction treatments. Urol. Oncol.26(3), 281–285(2008).
  • Althof SE , LeiblumSR, Chevret-MeassonMet al. Psychological and interpersonal dimensions of sexual function and dysfunction. J. Sex Med. 2, 793–800(2005).
  • Wiegel M , ScepkowskiLA, BarlowDH. Cognitive and affective processes in female sexual dysfunctions. In: Women‘s Sexual Function and Dysfunction: Study, Diagnosis and Treatment. Goldstein I, Meston CM, Davis SR, Traish AM (Eds). Taylor & Francis, Abingdon, UK (2006).
  • Latini DM , PensonDF, WallaceKL, LubeckDP, LueTF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. J. Sex Med.3(6), 1059–1067(2006).
  • Clement U . Systemische Sexualtherapie. Klett-Cotta Verlag, Stuttgart, Germany (2004).
  • Leiblum S , RosenR (Eds). Principles and Practice of Sex Therapy (3rd Edition). Guilford Press, New York, USA (2000).
  • Bitzer J , AlderJ. Sexualstörungen bei der Frau. Therapeutische Umschau67(3), 105–116(2010).
  • Goldstein I , AlexanderJL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J. Sex Med.2(Suppl. 3), 154–165(2005).
  • Simon J , BraunsteinGet al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. 90(9), 5226–5233(2005).
  • Buster JE , KingsbergSA, AguirreOet al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet. Gynecol. 105(5 Pt 1), 944–952(2005).
  • Shifren JL , DavisSRet al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results of the Intimate NM1 Study. Menopause 13(5), 770–779(2006).
  • Somboonporn W , DavisS, SeifMW, BellR. Testosterone for peri- and postmenopausal women. Cochrane Database Syst. Rev.4, CD004509 (2005).
  • North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 positions statement of the North American Menopause Society. Menopause14, 168–172(2007).
  • Somboonporn W , DavisSR. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr. Rev.25, 374–388(2004).
  • Davis SR , MoreauM, KrollRet al. APHRODITE study team: testosterone for low libido in postmenopausal women not taking estrogen. N. Engl. J. Med. 359(19), 2005–2017(2008).
  • Nijland EA , SchultzWCMW, Nathorst-BoösJet al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J. Sex Med. 5, 646–656(2008).
  • Laan E , van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric4(1), 28–41(2001).
  • Conner P . Breast response to menopausal hormone therapy – aspects on proliferation, apoptosis and mammographic density. Ann. Med.39, 28–41(2007).
  • Beral V . Million Women Study collaborators: breast cancer and hormone-replacement therapy in the Million Women Study. Lancet362(9382), 419–427(2003).
  • Basson R , McInnesR, SmithMD, HodgsonG, KoppikerN. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J. Womens Health Gend. Based Med.11, 367–377(2002).
  • Berman JR , BermanLA, TolerSM, GillJ, HaughieS. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J. Urol.170, 2333–2338(2003).
  • Balon R , SegravesRT. Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J. Sex. Marital Ther.34(4), 353–365(2008).
  • Clayton AH , WarnockJK, KornsteinSG, PinkertonR, Sheldon-KellerA, McGarveyEL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J. Clin. Psychiatry65, 62–67(2004).
  • Pfaus J , GiulianoF, GelezH. Bremelanotide: an overview of preclinical CNS effects on female sexual function. J. Sex Med.4(Suppl. 4), 269–279(2007).
  • Ferger B , ShimasakiM, CeciA, IttrichC, AllersKA, SommerB. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats. Naunyn Schmiedebergs Arch. Pharmacol.381(6), 573–579(2010).
  • Goldstein I , LueTF, Padma-NathanHet al. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 338, 1397 (1998).
  • Hellstrom WJ , GittelmanM, KarlinGet al. Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology 61, 8 (2003).
  • Porst H , Padma-NathanH, GiulianoF, AnglinG. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology62, 121 (2003).
  • Rendell MS , RajferJ, WickerPA, SmithMD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA281, 421 (1999).
  • Morales AM , MironeV, DeanJ, CostaP. Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence. Clin. Interv. Aging4, 463–472(2009).
  • Schover LR , FouladiRT, WarnekeCLet al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 95, 2397 (2002).
  • Fink HA , MacDonaldR, RuthsIRet al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch. Intern. Med. 162, 1342 (2002).
  • Reffelmann T , KlonerRA. Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr. Pharm. Des.12, 3485–3494(2006).
  • Dunn ME , AlthofSE, PerelmanMA. Phosphodiesterase type 5 inhibitors’ extended durations of response as a variable in the treatment of erectile dysfunction. Int. J. Impot. Res.19, 119–123(2007).
  • Guay AT , SparkRF, BansalSet al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple‘s problem – 2003 update. Endocr. Pract. 9, 77 (2003).
  • Banner LL , AndersonRU. Integrated sildenafil and cognitive-behavior sex therapy for psychogenic erectile dysfunction: a pilot study. J. Sex Med.4(4 Pt 2), 1117–1125(2007).
  • Heiman JR , TalleyDR, BailenJLet al. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectile dysfunction: a multicentre, randomised, double-blind, placebo-controlled trial. BJOG 114(4), 437–447(2007).
  • Goldstein I , FisherWA, SandMet al. Women‘s sexual functions improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. J. Sex Med. 2(6), 819–832(2005).
  • Wang WF , ChanL, MinhasS, RalöhDJ. Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Chin. Med. J. (Engl.)120(11), 1000–1006(2007).
  • McMahon CG . Dapoxetine for premature ejaculation. Exp. Opin. Pharmacother.11(10), 1741–1752(2010).
  • Montague DK , JarowJ, BroderickGAet al. AUA guideline on the pharmacologic management of premature ejaculation. J. Urol. 172, 290 (2004).
  • Taneja R . A rational combination pharmacotherapy in men with erectile dysfunction who initially failed to oral sildenafil citrate alone: a pilot study. J. Sex Med.4(4 Pt 2), 1136–1141(2007).
  • Shabsigh R , KaufmanJM, SteidleC, Padma-NathanH. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J. Urol.172, 658 (2004).
  • Yassin AA , SaadF. Testosterone and erectile dysfunction. J. Androl.29(6), 593–604(2008).
  • Bain J , BrockG, Kuzmarov I; International Consulting Group. Canadian Society for the Study of the Aging Male: response to health Canada‘s position paper on testosterone treatment. J. Sex Med.4(3), 558–566(2007).
  • Labrie F , Luu-TheV, BélangerA, LinSX, SimardJ, LabrieC. Is dehydroepiandrosterone a hormone? J. Endocrinol.187(2), 169–196(2005).
  • Labrie F , ArcherD, BouchardCet al. Effect on intravaginal prasterone (DHEA) on libido and sexual dysfunction in postmenopausal women. Menopause 16(5), 923–931(2009).
  • Panjari M , DavisSR. DHEA therapy for women: effect on sexual function and well being. Hum. Reprod. Update13(3), 239–248(2007).
  • Masters WH , JohnsonVE. Human Sexual Inadequacy. Little Brown, Boston, MA, USA (1970).
  • Barbach L . For Yourself. Ullstein, Berlin, Germany (1977).
  • LoPiccolo J , LoPiccoloL. Handbook of Sex Therapy. Plenum, New York, NY, USA (1978).
  • Levine SB , RisenCB, AlthofSE (Eds). Handbook of Clinical Sexuality for Mental Health Professionals. Brunner-Routledge, New York, USA (2003).
  • Vansteenwegen A . How can men and women in a couple bridge the difference between them? Sex. Marital Ther.13(4), 439–448(1998).
  • Pridal CG , LoPiccoloJ. Multielement treatment of desire disorders. In: Principles and Practice of Sex Therapy (3rd Edition). Leiblum SR, Rosen RC (Eds). Guilford Press, New York, USA (2000).
  • Brotto LA , BassonR, LuriaM. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J. Sex Med.5, 1646–1659(2008).
  • Brotto LA , BitzerJ, LaanE, LeiblumS, LuriaM. Women‘s sexual desire and arousal disorders. J. Sex Med.7, 586–614(2010).
  • Basson R , WiermannME, van Lankveld J, Brotto L. Summary of the recommendations on sexual dysfunctions in women. J. Sex Med.7, 314–326(2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.